The FGF ‐1‐specific single‐chain antibody scFv1C9 effectively inhibits breast cancer tumour growth and metastasis-Reference-Cited by-同舟云学术

The FGF ‐1‐specific single‐chain antibody scFv1C9 effectively inhibits breast cancer tumour growth and metastasis

Published:2014-08-15 Issue:10 Volume:18 Page:2061-2070
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Shi Hengliang¹²,Fu Chunling¹³,Wang Wei¹,Li Yu¹,Du Shuang¹,Cao Rangjuan¹,Chen Jingying¹,Sun Dong¹,Zhang Zhongyu¹,Wang Xingzhi¹,Zhu Xiaojuan¹

Affiliation:

1. Key Laboratory of Molecular Epigenetics of the Ministry of Education Institute of Cytology and Genetics Northeast Normal University Changchun China

2. Department of Neurosurgery Affiliated Hospital of Xuzhou Medical College Xuzhou China

3. Department of Hematology Affiliated Hospital of Xuzhou Medical College Xuzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.12371

Reference33 articles.

1. Fibroblast growth factors, their receptors and signaling.

2. A Hydrophobic Region Locating at the Center of Fibroblast Growth Factor-9 Is Crucial for Its Secretion

3. Secretion of FGF-16 Requires an Uncleaved Bipartite Signal Sequence

4. Fibroblast growth factor homologous factors: Evolution, structure, and function

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer immunotherapy using scFv antibody-based approaches, a systematic review;Human Immunology;2024-09

2. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer;Aging;2024-01-06

3. Not Only Immune Escape—The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis;Cancers;2021-05-28

4. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications;Current Drug Targets;2019-05-10

5. Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity;International Journal of Molecular Sciences;2018-08-21